Cargando…
Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649316/ http://dx.doi.org/10.1186/2051-1426-3-S2-P355 |
| _version_ | 1782401331562020864 |
|---|---|
| author | Farren, Matthew R Shakya, Reena Hennessey, Rebecca Mace, Thomas Yang, Jennifer Elnaggar, Omar Young, Gregory Landesman, Yosef Carlson, Robert Elloul, Sivan Crochiere, Marsha Burd, Christin Lesinski, Gregory |
| author_facet | Farren, Matthew R Shakya, Reena Hennessey, Rebecca Mace, Thomas Yang, Jennifer Elnaggar, Omar Young, Gregory Landesman, Yosef Carlson, Robert Elloul, Sivan Crochiere, Marsha Burd, Christin Lesinski, Gregory |
| author_sort | Farren, Matthew R |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4649316 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46493162015-11-24 Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma Farren, Matthew R Shakya, Reena Hennessey, Rebecca Mace, Thomas Yang, Jennifer Elnaggar, Omar Young, Gregory Landesman, Yosef Carlson, Robert Elloul, Sivan Crochiere, Marsha Burd, Christin Lesinski, Gregory J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649316/ http://dx.doi.org/10.1186/2051-1426-3-S2-P355 Text en Copyright © 2015 Farren et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Farren, Matthew R Shakya, Reena Hennessey, Rebecca Mace, Thomas Yang, Jennifer Elnaggar, Omar Young, Gregory Landesman, Yosef Carlson, Robert Elloul, Sivan Crochiere, Marsha Burd, Christin Lesinski, Gregory Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma |
| title | Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma |
| title_full | Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma |
| title_fullStr | Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma |
| title_full_unstemmed | Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma |
| title_short | Selinexor, a selective inhibitor of nuclear export (SINE), shows enhanced activity in combination with PD-1/PD-L1 blockade in syngeneic murine models of colon cancer and melanoma |
| title_sort | selinexor, a selective inhibitor of nuclear export (sine), shows enhanced activity in combination with pd-1/pd-l1 blockade in syngeneic murine models of colon cancer and melanoma |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649316/ http://dx.doi.org/10.1186/2051-1426-3-S2-P355 |
| work_keys_str_mv | AT farrenmatthewr selinexoraselectiveinhibitorofnuclearexportsineshowsenhancedactivityincombinationwithpd1pdl1blockadeinsyngeneicmurinemodelsofcoloncancerandmelanoma AT shakyareena selinexoraselectiveinhibitorofnuclearexportsineshowsenhancedactivityincombinationwithpd1pdl1blockadeinsyngeneicmurinemodelsofcoloncancerandmelanoma AT hennesseyrebecca selinexoraselectiveinhibitorofnuclearexportsineshowsenhancedactivityincombinationwithpd1pdl1blockadeinsyngeneicmurinemodelsofcoloncancerandmelanoma AT macethomas selinexoraselectiveinhibitorofnuclearexportsineshowsenhancedactivityincombinationwithpd1pdl1blockadeinsyngeneicmurinemodelsofcoloncancerandmelanoma AT yangjennifer selinexoraselectiveinhibitorofnuclearexportsineshowsenhancedactivityincombinationwithpd1pdl1blockadeinsyngeneicmurinemodelsofcoloncancerandmelanoma AT elnaggaromar selinexoraselectiveinhibitorofnuclearexportsineshowsenhancedactivityincombinationwithpd1pdl1blockadeinsyngeneicmurinemodelsofcoloncancerandmelanoma AT younggregory selinexoraselectiveinhibitorofnuclearexportsineshowsenhancedactivityincombinationwithpd1pdl1blockadeinsyngeneicmurinemodelsofcoloncancerandmelanoma AT landesmanyosef selinexoraselectiveinhibitorofnuclearexportsineshowsenhancedactivityincombinationwithpd1pdl1blockadeinsyngeneicmurinemodelsofcoloncancerandmelanoma AT carlsonrobert selinexoraselectiveinhibitorofnuclearexportsineshowsenhancedactivityincombinationwithpd1pdl1blockadeinsyngeneicmurinemodelsofcoloncancerandmelanoma AT elloulsivan selinexoraselectiveinhibitorofnuclearexportsineshowsenhancedactivityincombinationwithpd1pdl1blockadeinsyngeneicmurinemodelsofcoloncancerandmelanoma AT crochieremarsha selinexoraselectiveinhibitorofnuclearexportsineshowsenhancedactivityincombinationwithpd1pdl1blockadeinsyngeneicmurinemodelsofcoloncancerandmelanoma AT burdchristin selinexoraselectiveinhibitorofnuclearexportsineshowsenhancedactivityincombinationwithpd1pdl1blockadeinsyngeneicmurinemodelsofcoloncancerandmelanoma AT lesinskigregory selinexoraselectiveinhibitorofnuclearexportsineshowsenhancedactivityincombinationwithpd1pdl1blockadeinsyngeneicmurinemodelsofcoloncancerandmelanoma |